Erythematous (Type One) Rosacea Clinical Trial
Official title:
A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Dose-Response Profile of V-101 Cream in Subjects With Erythematous Rosacea
The purpose of this study is to evaluate the dose-response relationship (effect) of four concentrations of V-101 Cream in patients with erythematous(redness) rosacea.
Patients must have moderate to severe erythematous (facial redness) rosacea
- Male and female patients must be at least 18 years old and in good general health
- Female patients must not be pregnant or nursing
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment